What can we help you find?
Paul Dobesh, PharmD, FCCP, BCPS, discusses the data regarding the use of DOACs in obese patients with VTE.
Pharmacy Times® interviewed Steven Lucio, vice president of Pharmacy Solutions at Vizient, on a drug price forecast that estimates an increase in hospital drug spending in 2021.
Pharmacy Times spoke with Russell Procopio, executive vice president of Long-Term Care Pharmacy, about a new study regarding long-term care outcomes and cost.
Jacob Kettle, PharmD, BCOP, and Allison Butts, PharmD, BCOP, share some future therapies for the management of breast cancer.
Paul Dobesh, PharmD, FCCP, BCPS, shares data from several studies looking at the use of DOACs in the obese population.
The panel discusses the risks and benefits of warfarin in the use of thrombosis.
Pharmacy Times® interviewed Anne Marie Kondic, PharmD, on the grant opportunities the Community Pharmacy Foundation has supported to promote research and collaboration in the practice of the community pharmacy.
Jacob Kettle, PharmD, BCOP, and Allison Butts, PharmD, BCOP, consider the influence of COVID-19 on the therapeutic choice for patients.
A discussion on the impact and the use of telehealth in the management of patients during the COVID-19 pandemic.
Pharmacy Times spoke with Mark Calarco, MD, National Medical Director for Clinical Diagnostics, American Addiction Centers, about International Overdose Awareness Day.
The panel of experts in cardiology share their insights and the implications of the ISTH 2016 statement for DOACs.
Although the development process for vaccines is always intricate and time-consuming, the process of developing a vaccine for coronavirus disease 2019 (COVID-19) presents a myriad of new challenges, as researchers race to complete it in record time.